Pharmaceutical Executive January 12, 2022
Biopharma must step up amidst growing oncology market.
Decades of research led to significant breakthroughs in oncology drug development, and it has created much hope for cancer patients with lifesaving or life-enhancing medicines. Today, a few cancers are curative, and some are turned into chronic diseases; however, significant unmet needs remain across most cancers. More than 19M new cancer cases are diagnosed each year, and the oncology market valued at more than a hundred billion dollars in the US alone continues to grow. Today, almost one-third of the industry pipeline is concentrated in oncology which is exciting for patients and caregivers. This article shares our perspectives on key trends shaping the oncology marketplace and how biopharma must adapt to stay...
Today's Sponsors
Today's Sponsor